Want to join the conversation?
Medical device company $SRDX said it has enrolled the first patient in an early feasibility study of its SurVeil drug-coated balloon (DCB). The SurVeil DCB includes company's new coating formulation for interventional vascular treatment of peripheral artery disease and is the first vascular medical device that will be clinically tested by $SRDX.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?